Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.
2.

Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.

Nishioka M, Shimada M, Kurita N, Iwata T, Morimoto S, Yoshikawa K, Higashijima J, Miyatani T.

Hepatogastroenterology. 2012 Oct;59(119):2142-6.

PMID:
22366527
3.

[A Case of Locally Advanced Rectal Cancer with a Pathological Complete Response to Preoperative Chemoradiotherapy].

Akahoshi S, Iizaka M, Murakami S, Nimura S, Takeguchi T.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2316-8. Japanese.

PMID:
26805349
4.

[A case of advanced rectal cancer treated effectively with intersphincteric resection and preoperative chemotherapy].

Kimura A, Nishikawa S, Yachi T, Ito Y, Kudo Y, Kubo N, Tokura T, Umehara Y, Kurushima M, Takahashi K, Morita T.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2201-3. Japanese.

PMID:
23268023
5.

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.

Zhu J, Gu W, Lian P, Sheng W, Cai G, Shi D, Cai S, Zhang Z.

Radiat Oncol. 2013 May 29;8:130. doi: 10.1186/1748-717X-8-130.

6.

[A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].

Sueda T, Noura S, Ohue M, Shingai T, Gotoh K, Motoori M, Takahashi H, Kishi K, Marubashi S, Fujiwara Y, Ohigashi H, Yano M, Tomita Y, Ishikawa O.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1965-7. Japanese.

PMID:
24393981
7.

Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.

Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.

Ann Surg Oncol. 2012 Jul;19(7):2178-85. doi: 10.1245/s10434-012-2248-z. Epub 2012 Mar 7.

PMID:
22395978
8.

[A case report of pathologically complete response of rectal cancer after preoperative treatment of CPT-11, S-1, and radiation therapy].

Hamanaka M, Yamano T, Noda M, Tsukamoto K, Kuno T, Yamagishi D, Babaya A, Matsubara N, Kamikonya N, Tomita N.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2253-5. Japanese.

PMID:
22202346
9.

[A case of locally advanced rectal carcinoma treated with preoperative chemoradiotherapy resulting in pathologically complete response].

Katsuyama S, Murata M, Tanaka N, Asai K, Saso K, Yagi T, Yamada M, Sawami H, Takahashi H, Takayama O, Baba M, Kondo S, Son M, Kimura H, Fukuda H, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1563-5. Japanese.

PMID:
25731253
10.

[Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].

Murata K, Okamura S, Okubo H, Owada Y, Nishigaki T, Wada Y, Kato R, Makino S, Takeoka T, Okada K, Fukuchi N, Ebisui C, Kinuta M.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2020-2. Japanese.

PMID:
24393999
11.

A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.

Zhao L, Bai C, Shao Y, Guan M, Jia N, Xiao Y, Qiu H, Zhang F, Yang T, Zhong G, Chen S.

Cancer Lett. 2011 Nov 28;310(2):134-9. doi: 10.1016/j.canlet.2011.06.026. Epub 2011 Jul 5.

PMID:
21782322
12.

Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?

Lombardi R, Cuicchi D, Pinto C, Di Fabio F, Iacopino B, Neri S, Tardio ML, Ceccarelli C, Lecce F, Ugolini G, Pini S, Di Tullio P, Taffurelli M, Minni F, Martoni A, Cola B.

Ann Surg Oncol. 2010 Mar;17(3):838-45. doi: 10.1245/s10434-009-0796-7. Epub 2009 Dec 12.

PMID:
20012700
13.

T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.

Martijnse IS, Dudink RL, Kusters M, Vermeer TA, West NP, Nieuwenhuijzen GA, van Lijnschoten I, Martijn H, Creemers GJ, Lemmens VE, van de Velde CJ, Sebag-Montefiore D, Glynne-Jones R, Quirke P, Rutten HJ.

Ann Surg Oncol. 2012 Feb;19(2):392-401. doi: 10.1245/s10434-011-1955-1. Epub 2011 Jul 27.

PMID:
21792506
14.

[A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].

Kitahara T, Takemasa I, Inoue A, Osawa H, Miyo M, Mokutani Y, Ogawa H, Naito A, Hamabe A, Hiraki M, Munakata K, Uemura M, Nishimura J, Hata T, Mizushima T, Yamamoto H, Doki Y, Mori M.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1569-71. Japanese.

PMID:
25731255
15.

[A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].

Miyazawa T, Ebe K, Fujita N, Koide N, Honma K, Ikarashi T.

Gan To Kagaku Ryoho. 2012 Jun;39(6):1001-3. Japanese.

PMID:
22705702
16.

Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.

Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, Cellini F, Barbaro B, Cogliandolo S, Nuzzo G, Doglietto GB, Ambesi-Impiombato F, Cosimelli M.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):664-74.

PMID:
12062610
17.

Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.

Arbea L, Martínez-Monge R, Díaz-González JA, Moreno M, Rodríguez J, Hernández JL, Sola JJ, Ramos LI, Subtil JC, Nuñez J, Chopitea A, Cambeiro M, Gaztañaga M, García-Foncillas J, Aristu J.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):587-93. doi: 10.1016/j.ijrobp.2011.06.2008. Epub 2011 Nov 11.

PMID:
22079731
18.

Laparoscopic abdominosacral resection for locally advanced primary rectal cancer after treatment with mFOLFOX6 plus bevacizumab, followed by preoperative chemoradiotherapy.

Nagasaki T, Akiyoshi T, Ueno M, Fukunaga Y, Nagayama S, Fujimoto Y, Konishi T, Yamaguchi T.

Asian J Endosc Surg. 2014 Jan;7(1):52-5. doi: 10.1111/ases.12068.

PMID:
24450344
19.

Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.

Lee SH, Lee KC, Choi JH, Oh JH, Baek JH, Park SH, Shin DB.

Jpn J Clin Oncol. 2008 Feb;38(2):112-21. doi: 10.1093/jjco/hym164. Epub 2008 Feb 8.

PMID:
18263881
20.

Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

Nogué M, Salud A, Vicente P, Arriví A, Roca JM, Losa F, Ponce J, Safont MJ, Guasch I, Moreno I, Ruiz A, Pericay C; AVACROSS Study Group.

Oncologist. 2011;16(5):614-20. doi: 10.1634/theoncologist.2010-0285. Epub 2011 Apr 5.

Supplemental Content

Support Center